| Literature DB >> 21909072 |
Gaetana Restivo1, Bach-Cuc Nguyen, Piotr Dziunycz, Elodie Ristorcelli, Russell J H Ryan, Özden Yalçin Özuysal, Matteo Di Piazza, Freddy Radtke, Michael J Dixon, Günther F L Hofbauer, Karine Lefort, G Paolo Dotto.
Abstract
While the pro-differentiation and tumour suppressive functions of Notch signalling in keratinocytes are well established, the underlying mechanisms remain poorly understood. We report here that interferon regulatory factor 6 (IRF6), an IRF family member with an essential role in epidermal development, is induced in differentiation through a Notch-dependent mechanism and is a primary Notch target in keratinocytes and keratinocyte-derived SCC cells. Increased IRF6 expression contributes to the impact of Notch activation on growth/differentiation-related genes, while it is not required for induction of 'canonical' Notch targets like p21(WAF1/Cip1), Hes1 and Hey1. Down-modulation of IRF6 counteracts differentiation of primary human keratinocytes in vitro and in vivo, promoting ras-induced tumour formation. The clinical relevance of these findings is illustrated by the strikingly opposite pattern of expression of Notch1 and IRF6 versus epidermal growth factor receptor in a cohort of clinical SCCs, as a function of their grade of differentiation. Thus, IRF6 is a primary Notch target in keratinocytes, which contributes to the role of this pathway in differentiation and tumour suppression.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21909072 PMCID: PMC3243593 DOI: 10.1038/emboj.2011.325
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598